Deep Intronic ETFDH Variants Represent a Recurrent Pathogenic Event in Multiple Acyl-CoA Dehydrogenase Deficiency
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25179637 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Stefania Martino und 19 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70124 Bari, Ita…. Hauptthemen laut MEDLINE: Multiple Acyl Coenzyme A Dehydrogenase Deficiency, Electron-Transferring Flavoproteins, Oxidoreductases Acting on CH-NH Group Donors, Iron-Sulfur Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health project "Genoma mEdiciNa pERsonalizzata" (GENERA), ELIXIRNextGenIT, National Center for Gene Therapy and Drugs Based on RNA Technology- MUR.
Abstract (Originalsprache)
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a rare inborn error of metabolism affecting fatty acid and amino acid oxidation with an incidence of 1 in 200,000 live births. MADD has three clinical phenotypes: severe neonatal-onset with or without congenital anomalies, and a milder late-onset form. Clinical diagnosis is supported by urinary organic acid and blood acylcarnitine analysis using tandem mass spectrometry in newborn screening programs. MADD is an autosomal recessive trait caused by biallelic mutations in the ETFA, ETFB, and ETFDH genes encoding the alpha and beta subunits of the electron transfer flavoprotein (ETF) and ETF-coenzyme Q oxidoreductase enzymes. Despite significant advancements in sequencing techniques, many patients remain undiagnosed, impacting their access to clinical care and genetic counseling. In this report, we achieved a definitive molecular diagnosis in a newborn by combining whole-genome sequencing (WGS) with RNA sequencing (RNA-seq). Whole-exome sequencing and next-generation gene panels fail to detect variants, possibly affecting splicing, in deep intronic regions. Here, we report a unique deep intronic mutation in intron 1 of the ETFDH gene, c.35-959A>G, in a patient with early-onset lethal MADD, resulting in pseudo-exon inclusion. The identified variant is the third mutation reported in this region, highlighting ETFDH intron 1 vulnerability. It cannot be excluded that these intronic sequence features may be more common in other genes than is currently believed. This study highlights the importance of incorporating RNA analysis into genome-wide testing to reveal the functional consequences of intronic mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genetics Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70124 Bari, Italy.
- Department of Biosciences, Biotechnologies & Environment, University of Bari "Aldo Moro", Via Edoardo Orabona 4, 70125 Bari, Italy.
- Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, Viale di San Paolo 15, 00146 Rome, Italy.
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
- Section of Neonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, University of Bari "Aldo Moro", 70121 Bari, Italy.
- Clinical Pathology and Neonatal Screening, Hospital "Giovanni XXIII", University Hospital Consortium Corporation Polyclinics of Bari, 70124 Bari, Italy.
ORCID-Profile: Pietro D'Addabbo, Francesca Clementina Radio, Alessandro Bruselles, Alessandro Stella, Nicola Laforgia, Orazio Palumbo, Marco Tartaglia, Graziano Pesole, Nicoletta Resta
Förderung
- Ministry of Health project "Genoma mEdiciNa pERsonalizzata" (GENERA)
- ELIXIRNextGenIT
- National Center for Gene Therapy and Drugs Based on RNA Technology- MUR
- National Center for Gene Therapy and Drugs Based on RNA Technology-MUR
- Ministry of Health project “Genoma mEdiciNa pERsonalizzata”
- Ministry of Health
- Ministry of Research
Zitieren
APA
Martino, S., D'Addabbo, P., Turchiano, A., Radio, F. C., Bruselles, A., Cordeddu, V., Mancini, C., Stella, A., Laforgia, N., Capodiferro, D., Simonetti, S., Bagnulo, R., Palumbo, O., Marzano, F., Tabaku, O., Garganese, A., Stasi, M., Tartaglia, M., Pesole, G., & Resta, N. (2024). Deep Intronic ETFDH Variants Represent a Recurrent Pathogenic Event in Multiple Acyl-CoA Dehydrogenase Deficiency. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179637
Vancouver
Martino S, D'Addabbo P, Turchiano A, Radio FC, Bruselles A, Cordeddu V, et al. Deep Intronic ETFDH Variants Represent a Recurrent Pathogenic Event in Multiple Acyl-CoA Dehydrogenase Deficiency. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179637
BibTeX
@article{Martino2024,
author = {Martino, Stefania and D'Addabbo, Pietro and Turchiano, Antonella and Radio, Francesca Clementina and Bruselles, Alessandro and Cordeddu, Viviana and Mancini, Cecilia and Stella, Alessandro and Laforgia, Nicola and Capodiferro, Donatella and Simonetti, Simonetta and Bagnulo, Rosanna and Palumbo, Orazio and Marzano, Flaviana and Tabaku, Ornella and Garganese, Antonella and Stasi, Michele and Tartaglia, Marco and Pesole, Graziano and Resta, Nicoletta},
title = {Deep Intronic ETFDH Variants Represent a Recurrent Pathogenic Event in Multiple Acyl-CoA Dehydrogenase Deficiency},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25179637}
}
EUVIMED